Skip to the page

Data / Form D filings / Encore Well Labs Plus Fund, LP

Encore Well Labs Plus Fund, LP: Form D filing

Encore Well Labs Plus Fund, LP, a health care company in Clayton, MO, filed a Form D with the SEC in 2023. The latest, on August 4, 2023, reports $16.4 million sold of a $21.4 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8008 Carondelet Avenue, Clayton, MO, 63105
Phone
(314) 973-4557
Industry
Other Health Care
Entity type
Limited Partnership
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b), Investment Company Act section 3(c), section 3(c)(1), section 3(c)(7)
SEC identifier (CIK)
1988112

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 4, 2023New notice$21,400,000$16,400,000$5,000,00012Jul 31, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Greg SiwakExecutive Officer
Todd SiwakExecutive Officer
N/A Encore Well Labs Plus GP, LLCDirector

Other health care companies in Missouri that filed recently

Every Form D from the week of Jul 31, 2023 · All recent filings in Missouri · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Encore Well Labs Plus Fund, LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.